Dermatology
Latest News
Experts share their sun protection tips for children
Most sunscreens are not approved for use in children under the age of 6 months because testing has not been done in this age group, Dr. Adelaide A...
Latest News
Low-dose oral minoxidil for hair loss soars after NYT article
Dermatologists are increasingly familiar with the medication, but a popular media report seems to have resulted in a quick uptake.
Latest News
Report eyes complications from microwave energy devices for hyperhidrosis
The study authors recommend questioning patients about hidradenitis suppurativa (HS) history and examining for HS clinical findings before using...
Latest News
Advising patients on AD treatment options: Expert pearls
Dupilumab dosing and dupilumab-associated facial redness and ocular disease, self-image issues, topical regimen adherence, and the quantification...
Latest News
How does psoriasis affect fertility and birth outcomes?
“The mechanism to link the higher risk of pregnancy loss in patients with psoriasis is not clear,” the authors wrote.
Conference Coverage
Halting active inflammation key in treating PIH
“Most of my patients come in not even worried about the acne. ... They come in wanting me to fix the dark spots,” says Seemal Desai, MD.
Latest News
Macular dermal hyperpigmentation: Treatment tips from an expert
Expert provides tips on treating some tough-to-treat dermatologic conditions: lichen planus pigmentosus, ochronosis, and drug-induced facial...
Latest News
Tips, contraindications for superficial chemical peels reviewed
Setting expectations is critical as it can take a series of peels over months to see results.
Latest News
Cell activity in psoriasis may predict disease severity and provide clues to comorbidities
Skin samples from patients with psoriasis showed more fibroblast clusters in the upper layers of the skin in moderate to severe cases.
Latest News
Lower racial disparity in melanoma diagnoses in vets than U.S. men overall, study finds
Melanoma was the fourth-most common cancer diagnosed in male VA patients.
Latest News
Abrocitinib remains effective at 96 weeks, in older as well as younger adults
The analysis stratified patients by age – 18-50 and over 50 years – and found that the sustained improvement with the JAK-1 selective inhibitor as...